EMBIO Diagnostics and Abdulla Fouad Group’s MTS enter exclusive distribution agreement

09:00 - 17 June 2024

Companies Reporter

MTS company, part of Saudi Arabia’s Abdulla Fouad Group, has signed an exclusive distribution agreement with Cyprus-based EMBIO Diagnostics.

In a LinkedIn post, Bassam Zaaza, Director of Medical Technology Solutions Co. & Laboratories (MTS), which is part of Abdulla Fouad Group, said, “I trust this strategic agreement will promote the advancement of the medical sector of Saudi Arabia, and will push its boundaries to the next level.”

In his post, Zaaza also notes, “EMBIO Diagnostics is a biotechnology company that creates and advances cutting-edge, portable digital devices using biosensor technology for fast diagnostic purposes. EMBIO's devices find applications covering the needs of a wide range of industries including Environmental, Food safety and Medical sectors.”

Abdulla Fouad Group is a diversified business group that serves the Oil & Gas, Energy, Healthcare, Information Technology, Consumer, and Construction sectors, among others.

EMBIO Diagnostics and Abdulla Fouad Group’s MTS enter exclusive distribution agreement

News Feed

Read More